SEI Investments’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Sell |
167,274
-24,486
| -13% | -$1.57M | 0.01% | 1025 |
|
|
2026
Q1 | $10.8M | Buy |
191,760
+24,404
| +15% | +$1.59M | 0.01% | 1101 |
|
|
2025
Q4 | $13.4M | Sell |
167,356
-248
| -0.1% | -$16.7K | 0.01% | 918 |
|
|
2025
Q3 | $8.17M | Sell |
167,604
-28,613
| -15% | -$1.77M | 0.01% | 1100 |
|
|
2025
Q2 | $14.6M | Buy |
196,217
+20,731
| +12% | +$1.37M | 0.02% | 824 |
|
|
2025
Q1 | $11.2M | Buy |
175,486
+29,482
| +20% | +$2.01M | 0.01% | 925 |
|
|
2024
Q4 | $11.4M | Buy |
146,004
+11,576
| +9% | +$930K | 0.01% | 929 |
|
|
2024
Q3 | $10.8M | Buy |
134,428
+1,954
| +1% | +$158K | 0.01% | 957 |
|
|
2024
Q2 | $11M | Buy |
132,474
+8,987
| +7% | +$791K | 0.02% | 876 |
|
|
2024
Q1 | $10.5M | Sell |
123,487
-3,939
| -3% | -$309K | 0.02% | 894 |
|
|
2023
Q4 | $10.9M | Sell |
127,426
-3,102
| -2% | -$268K | 0.02% | 846 |
|
|
2023
Q3 | $11.7M | Buy |
130,528
+7,998
| +7% | +$714K | 0.02% | 772 |
|
|
2023
Q2 | $10.4M | Buy |
122,530
+6,998
| +6% | +$592K | 0.02% | 851 |
|
|
2023
Q1 | $9.56M | Buy |
115,532
+2,332
| +2% | +$189K | 0.02% | 872 |
|
|
2022
Q4 | $8.9M | Buy |
113,200
+10,855
| +11% | +$872K | 0.02% | 778 |
|
|
2022
Q3 | $7.58M | Buy |
102,345
+2,424
| +2% | +$174K | 0.02% | 889 |
|
|
2022
Q2 | $6.53M | Buy |
99,921
+18,365
| +23% | +$1.09M | 0.01% | 972 |
|
|
2022
Q1 | $5.18M | Buy |
81,556
+1,879
| +2% | +$102K | 0.01% | 1087 |
|
|
2021
Q4 | $4.22M | Buy |
79,677
+720
| +0.9% | +$43.9K | 0.01% | 1221 |
|
|
2021
Q3 | $5.57M | Buy |
78,957
+2,587
| +3% | +$163K | 0.01% | 1026 |
|
|
2021
Q2 | $5.08M | Buy |
76,370
+19,589
| +34% | +$1.39M | 0.01% | 1065 |
|
|
2021
Q1 | $6.33M | Buy |
56,781
+240
| +0.4% | +$29.7K | 0.02% | 909 |
|
|
2020
Q4 | $6.71M | Sell |
56,541
-5,671
| -9% | -$611K | 0.02% | 830 |
|
|
2020
Q3 | $5.43M | Sell |
62,212
-214,968
| -78% | -$18.8M | 0.02% | 834 |
|
|
2020
Q2 | $24.8M | Buy |
277,180
+81,845
| +42% | +$8.27M | 0.08% | 252 |
|
|
2020
Q1 | $19.5M | Buy |
195,335
+2,259
| +1% | +$245K | 0.07% | 266 |
|
|
2019
Q4 | $22.2M | Sell |
193,076
-3,781
| -2% | -$457K | 0.07% | 290 |
|
|
2019
Q3 | $24.8M | Sell |
196,857
-26,417
| -12% | -$3.35M | 0.06% | 281 |
|
|
2019
Q2 | $26.9M | Buy |
223,274
+53,925
| +32% | +$5.31M | 0.09% | 232 |
|
|
2019
Q1 | $14.8M | Buy |
169,349
+37,106
| +28% | +$3.37M | 0.05% | 395 |
|
|
2018
Q4 | $14.9M | Buy |
132,243
+17,730
| +15% | +$1.86M | 0.05% | 390 |
|
|
2018
Q3 | $13.1M | Sell |
114,513
-17,337
| -13% | -$1.79M | 0.05% | 414 |
|
|
2018
Q2 | $11.8M | Buy |
131,850
+118,305
| +873% | +$9.99M | 0.04% | 492 |
|
|
2018
Q1 | $990K | Buy |
13,545
+3,103
| +30% | +$213K | ﹤0.01% | 1425 |
|
|
2017
Q4 | $606K | Buy |
10,442
+7,786
| +293% | +$410K | ﹤0.01% | 1624 |
|
|
2017
Q3 | $119K | Buy |
2,656
+699
| +36% | +$29K | ﹤0.01% | 2030 |
|
|
2017
Q2 | $77K | Buy |
1,957
+188
| +11% | +$7.72K | ﹤0.01% | 2130 |
|
|
2017
Q1 | $72K | Sell |
1,769
-9,720
| -85% | -$380K | ﹤0.01% | 2033 |
|
|
2016
Q4 | $462K | Buy |
11,489
+10,360
| +918% | +$391K | ﹤0.01% | 1600 |
|
|
2016
Q3 | $41K | Sell |
1,129
-1,572
| -58% | -$54K | ﹤0.01% | 2112 |
|
|
2016
Q2 | $78K | Sell |
2,701
-1,088
| -29% | -$32.9K | ﹤0.01% | 1799 |
|
|
2016
Q1 | $132K | Sell |
3,789
-150,296
| -98% | -$4.85M | ﹤0.01% | 1608 |
|
|
2015
Q4 | $4.97M | Sell |
154,085
-35,305
| -19% | -$1.15M | 0.03% | 658 |
|
|
2015
Q3 | $6.12M | Buy |
189,390
+9,921
| +6% | +$373K | 0.06% | 400 |
|
|
2015
Q2 | $7.42M | Buy |
179,469
+606
| +0.3% | +$25.5K | 0.07% | 346 |
|
|
2015
Q1 | $8.04M | Buy |
178,863
+24,794
| +16% | +$1.04M | 0.07% | 327 |
|
|
2014
Q4 | $5.76M | Buy |
+154,069
| New | +$5.64M | 0.05% | 395 |
|
Other funds holding HAE
AI
SEI Investments's HAE Position: Q2 2026 in Review
SEI Investments reduced its Haemonetics (HAE) stake by 13% in Q2 2026, selling an estimated $1.57M and leaving 167,274 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1025.
SEI Investments first reported a position in HAE in Q4 2014 and has held it in 47 quarters since. The position peaked at $26.9M in Q2 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- SEI Investments held 167,274 shares of Haemonetics worth $12.5M as of Q2 2026.
- SEI Investments sold 24,486 Haemonetics shares in Q2 2026, an estimated $1.57M.
- Haemonetics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1025 holding.
- SEI Investments first reported a position in Haemonetics in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's Haemonetics position peaked at $26.9M in Q2 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.